Silicon Republic – Cork medtech firm AventaMed secures €1.8m to take grommets Stateside

Please link to the article below by Colm Gorey which was posted in Oct 2017 by siliconrepublic.com website.

The Cork company AventaMed which is a spin-out from CIT has announced a new round of funding from HBAN of €1.8m. This funding will enable AventaMed to cover the FDA approval for their innovative medical device, known as Solo Tympanostomy Tube Device or Solo TTD, to commercialise it and take it Stateside.

You can access further information reading the full article by clicking on the button below.

Share This Post!

If you are interested in becoming an Investor or seeking investment, then please contact us.